For instance, Zimmer Biomet and Arthrogenics announced a partnership in April 2024 to develop next-generation cartilage ...

Truist analyst Richard Newitter lowered the firm’s price target on Zimmer Biomet (ZBH) to $113 from $118 and keeps a Hold rating on the shares.

Barclays lowered the firm’s price target on Zimmer Biomet (ZBH) to $112 from $118 and keeps an Underweight rating on the shares. The firm ...

For Dr. Jason Rich, Friday night’s Daddy’s Little Sweetheart Dance at the Zimmer Biomet Center Lake Pavilion was a little bittersweet.

Shares of Zimmer Biomet Holdings Inc. ZBH shed 1.71% to $100.93 Friday, on what proved to be an all-around rough trading ...

Surgery Partners. In 2024, Surgery Partners added five new ASCs and two orthopedic ASCs in Chicago through a partnership with Duly Health. It also added over 230 physicians across orthopedics, spine ...

Q4 2024 Earnings Call Transcript February 6, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is ...

NEW YORK, Feb. 7, 2025 /PRNewswire/ -- With thousands of press releases published each month, it can be difficult to keep up ...

Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...

Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the ...

Shares of Zimmer Biomet Holdings Inc. ZBH slipped 5.14% to $102.69 Thursday, on what proved to be an all-around mixed trading ...

Through the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment to outpace hips and knees, moving forward, according to a Feb. 6 report from Medtech ...